Detall de la convocatòria


Objectiu de la convocatòria
The program is designed to support innovative translational research projects in hematologic malignancies, performed by early to mid-career scientists, that can be based around either a clinical trial or laboratory investigation.
Lloc de presentació
IMIM and PSMAR staff who need more information should contact::
Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
Carol Barnwell: Ext.: 1670
Marta López: Ext.: 1576
Convocatòria (URL)
Applicants must meet the following requirements:
  • Hold an MD or PhD (equivalent degree) at time of award. MD qualifications would have to have been obtained within the last 10 years and PhD qualifications would have to have been obtained within the last 5 years
  • Early to Mid-career scientists with a strong research track record who hold a position at a recognised research institution in one of the eligible countries at the time of application (see below for list of countries) and whose tenure of that position encompasses the projected period of the award from the Gilead and Kite scholarship program
  • Have a strong career interest in hematology/oncology
  • Have a research mentor with extensive experience in the field of hematology/oncology
  • Be able to devote at least 30% of professional time to research for the next two years (versus administrative, patient care, or teaching responsibilities)
  • Be able to complete the proposed research within the two-year award period, providing evidence (manuscript, presentation, or abstracts) resulting from the research Exceptions to the above can apply, for example, having taken time out for parental leave or family bereavement
  • The Research Scholars Program in hematologic malignancies is open to emerging investigators from countries with the following regions and countries: Europe, Asia, Australasia and South America​
  • An applicant must be a citizen or permanent resident of the country/region in which they propose to conduct the research, or otherwise hold a temporary study or nonimmigrant visa which allows legal residency in the country/region in which the research will be performed. Such visa must be valid for the two-year award period.

    Awards granted under the program may not be duplicative of funding from institutional or hospital, other governmental, non-governmental, or industry sources. Applicants seeking an award for research projects that are currently receiving or may receive partial funding from other sources are required to submit appropriate evidence, including budget information related to the other sources, to demonstrate that there is no overlap or duplication in funding, as outlined in the current and pending funding form.
  • Dotació
    Up to USD 180,000, payable in annual installments of up to USD 90,000 per year for 2 years.
    Two years.
    Applicants must complete the online Application Form at


    International Research Scholar Programme in Hematology-Oncology.pdf